Fast Five Quiz: Urticaria (Hives)

William James, MD


December 12, 2022

Second-generation H1-receptor blockers such as fexofenadine are the first-line treatment in acute urticaria. Avoidance of the offending substance is the cornerstone of management. Patients should be educated about cross-reactive proteins and avoiding exposure. 

First-generation antihistamines such as diphenhydramine are sedating and are no longer the first-line treatment for urticaria. H2 antagonists such as famotidine are not effective when used as single agents for urticaria; however, combined with an H1 antagonist, they have been shown to increase efficacy when used in combination with an H1 antagonist.

If urticaria is present with angioedema and systemic symptoms, which raises concern for anaphylaxis, epinephrine should be administered intramuscularly.

Learn more about fexofenadine.

This Fast Five Quiz was excerpted and adapted from the Medscape articles Urticaria, Acute Urticaria, Allergic Contact Dermatitis, and Fexofenadine.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.